ArticleFrontiers in immunology2026
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Introduction: Methods: Synovial biopsies from seven patients were exposed to three inoculate doses of Bb (250k, 500k, 1000k) in our Joint Space Analysis System (JSAS). Tissue samples and supernatant were collected at 24, 48, and 72 hours for histology, immunofluorescence (IF), RNAscope, and ELISA. Results: We found dose- and time-dependent changes in synovial intimal lining (IntL) thickness and cellularity. IntL integrity significantly decreased with 1000k Bb at Day 2 (p = 0.021) and remained decreased with 1000k Bb at Day 3 (p = 0.005). IF revealed sustained expression of the M2 marker CD206 in joint-lining macrophages despite infection. RNAscope demonstrated a spatially limited co-localization of Bb within the tissue and alteration of tight junction ZO-1 subcellular localization within the IntL. ELISA indicated reduced Osteoprotegerin at Day 3, suggesting potential for altered bone remodeling activity. IL-10 secretion increased over time and Bb dose. Discussion: These findings demonstrate that Bb interaction with joint-lining macrophages is associated with rapid, structural, and functional alterations, with loss of IntL integrity and macrophage dysregulation. Compromise of the synovial barrier may facilitate immune cell infiltration, contributing to disease pathogenesis, in the setting of increased markers of synovitis and increased regulatory cytokines, but causative association of these phenomena remains to be explored.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.